146 related articles for article (PubMed ID: 1383625)
61. Acute hemodynamic and neurohumoral profile of dilevalol in hypertensive patients with ischemic heart disease.
Remme WJ; von Schelven D; Bartels GL; Kruijssen HA; de Leeuw PW
J Cardiovasc Pharmacol; 1993 Aug; 22(2):327-35. PubMed ID: 7692177
[TBL] [Abstract][Full Text] [Related]
62. Effect of carnitine on myocardial function and metabolism following global ischemia.
Silverman NA; Schmitt G; Vishwanath M; Feinberg H; Levitsky S
Ann Thorac Surg; 1985 Jul; 40(1):20-4. PubMed ID: 4015239
[TBL] [Abstract][Full Text] [Related]
63. Dose related coronary and systemic haemodynamic effects of intravenous bepridil in patients with coronary artery disease.
Remme WJ; van Hoogenhuyze DC; Krauss XH; Hofman A; Storm CJ; Kruyssen HA
Eur Heart J; 1987 Feb; 8(2):130-40. PubMed ID: 3494607
[TBL] [Abstract][Full Text] [Related]
64. L-propionylcarnitine effect on postexercise and postischemic hyperemia in patients affected by peripheral vascular disease.
Corsi C; Pollastri M; Marrapodi E; Leanza D; Giordano S; D'Iddio S
Angiology; 1995 Aug; 46(8):705-13. PubMed ID: 7639417
[TBL] [Abstract][Full Text] [Related]
65. The rate-pressure product as an index of myocardial oxygen consumption during exercise in patients with angina pectoris.
Gobel FL; Norstrom LA; Nelson RR; Jorgensen CR; Wang Y
Circulation; 1978 Mar; 57(3):549-56. PubMed ID: 624164
[TBL] [Abstract][Full Text] [Related]
66. Improved pacing tolerance of the ischemic human myocardium after administration of carnitine.
Thomsen JH; Shug AL; Yap VU; Patel AK; Karras TJ; DeFelice SL
Am J Cardiol; 1979 Feb; 43(2):300-6. PubMed ID: 32761
[TBL] [Abstract][Full Text] [Related]
67. The effects of propionylcarnitine taurine on cardiac performance in aerobic and ischemic myocardium.
Molaparast-Saless F; Nellis SH; Liedkte AJ
J Mol Cell Cardiol; 1988 Jan; 20(1):63-74. PubMed ID: 3367380
[TBL] [Abstract][Full Text] [Related]
68. Additional antiischemic effects of long-term L-propionylcarnitine in anginal patients treated with conventional antianginal therapy.
Bartels GL; Remme WJ; den Hartog FR; Wielenga RP; Kruijssen DA
Cardiovasc Drugs Ther; 1995 Dec; 9(6):749-53. PubMed ID: 8850378
[TBL] [Abstract][Full Text] [Related]
69. Effects of 1-epinephrine on hemodynamics and cardiac function in coronary disease: dose-response studies.
Sung BH; Robinson C; Thadani U; Lee R; Wilson MF
Clin Pharmacol Ther; 1988 Mar; 43(3):308-16. PubMed ID: 3345621
[TBL] [Abstract][Full Text] [Related]
70. Cardioprotective effects of carnitine in extensive aortocoronary bypass grafting: a double-blind, randomized, placebo-controlled clinical trial.
Demeyere R; Lormans P; Weidler B; Minten J; Van Aken H; Flameng W
Anesth Analg; 1990 Nov; 71(5):520-8. PubMed ID: 2221413
[TBL] [Abstract][Full Text] [Related]
71. [Effect of digoxin on myocardial oxygen consumption in coronary heart disease].
Tauchert M; Behrenbeck DW; Hötzel J; Jansen W; Niehues B; Hilger HH
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1641-4. PubMed ID: 611899
[No Abstract] [Full Text] [Related]
72. Acute hemodynamic and antiischemic properties of intravenous bepridil in coronary artery disease.
Remme WJ; Kruyssen DA; Van Hoogenhuyze DC; Hofman B; Krauss XH; Storm CJ
Am J Cardiol; 1989 Mar; 63(11):670-5. PubMed ID: 2784281
[TBL] [Abstract][Full Text] [Related]
73. Acute myocardial uptake of digoxin in humans: correlation with hemodynamic and electrocardiographic effects.
Powell AC; Horowitz JD; Hasin Y; Syrjanen ML; Horomidis S; Louis WJ
J Am Coll Cardiol; 1990 May; 15(6):1238-47. PubMed ID: 2329227
[TBL] [Abstract][Full Text] [Related]
74. Effect of propionyl-L-carnitine on mechanical function of isolated rabbit heart.
Ferrari R; Pasini E; Condorelli E; Boraso A; Lisciani R; Marzo A; Visiou O
Cardiovasc Drugs Ther; 1991 Feb; 5 Suppl 1():17-23. PubMed ID: 2031870
[TBL] [Abstract][Full Text] [Related]
75. [Indices of intracardiac hemodynamics and of myocardial contractile function in relationship to the total coronary artery lesion in stenocardia].
Mamedkulieva AA
Kardiologiia; 1978 Jun; 18(6):76-9. PubMed ID: 672023
[TBL] [Abstract][Full Text] [Related]
76. Short-term hemodynamic effects of intravenous propionyl-L-carnitine in anesthetized dogs.
Cevese A; Schena F; Cerutti G
Cardiovasc Drugs Ther; 1991 Feb; 5 Suppl 1():45-56. PubMed ID: 2031871
[TBL] [Abstract][Full Text] [Related]
77. Effects of L- and DL-carnitine on patients with impaired exercise tolerance.
Watanabe S; Ajisaka R; Masuoka T; Yamanouchi T; Saitou T; Toyama M; Takeyasu N; Sakamoto K; Sugishita Y
Jpn Heart J; 1995 May; 36(3):319-31. PubMed ID: 7650839
[TBL] [Abstract][Full Text] [Related]
78. [The cardioprotective action of carnitine and its structural analog 3-(2,2,2-trimethylhydrazine)propionate on cardiac energy metabolism in experimental occlusion of the coronary artery in rats].
Ratunova TM; Bauman VR; Kalvin'sh IIa
Farmakol Toksikol; 1989; 52(5):24-7. PubMed ID: 2599072
[TBL] [Abstract][Full Text] [Related]
79. [Myocardial contractility during angina pectoris attack in ischemic heart disease].
Krol VA; Iurenev AP; Belenkov IuN; At'kov OIu; Fomina GA
Kardiologiia; 1977 Jan; 17(1):85-9. PubMed ID: 853602
[TBL] [Abstract][Full Text] [Related]
80. [Problems of digitalization in coronary disease].
Lehmann HU; Hochrein H
Med Klin; 1978 Feb; 73(6):179-88. PubMed ID: 340866
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
